Nature Research Custom Media

SARS-CoV-2 has driven the rapid development of a number of new vaccine technologies. The benefits will last long after the pandemic subsides. #AdFeature with @GSK

Could AI take the pain out of antibody selection? A new machine-learning platform can scour scientific literature to identify high-affinity antibodies. #AdFeature with @Illumina

DNA variations drive many different cardiovascular diseases, but genetic testing is not yet widely used. Lack of awareness is part of the reason. #AdFeature with @illumina

Tools such as CRISPR and machine learning are helping researchers screen for, and unlock the potential of synthetic lethality which could treat more patients with 'undruggable' cancers. #AdFeature with @GSK

For scientists engineering high-affinity antibodies, a new programmable semiconductor platform makes the construction of higher-quality mutant libraries precise and fast. #Adfeature with @GenScript

Can genomic technology help scientists prepare for the next pandemic? #AdFeature with @illumina

Biobanking has been around for decades now, having grown from small niche projects to large national undertakings. But is bigger always better? How can we ensure representation for all of the population? #AdFeature with @Illumina

Next-generation sequencing is helping researchers to understand why individuals respond differently to SARS-CoV-2 infection #AdFeature with @illumina

Pinpointing the role of microRNA in the circadian rhythm of skin cells could help identify methods to alleviate age-related damage #AdFeature with @EsteeLauder

As SARS-CoV-2 testing raises demand for antibodies, how is supply keeping up – while maintaining quality? #AdFeature with @JacksonImmunoR

A new method of validating antibodies for post-translational modification studies should improve experimental reproducibility by greatly increasing specificity #AdFeature with @invitrogen

A deeper understanding of the gut's microbiome through next-generation sequencing will help researchers better understand how our microbial inhabitants contribute to, or protect us from disease #AdFeature with @illumina

A new six-colour digital PCR system that rapidly detects tumour mutations could help guide faster treatment of diseases such as non-small cell lung cancer #AdFeature with @StillaTech

Two complementary workflows have been developed that can be performed alongside traditional PCR testing methods #AdFeature with @illumina

Once considered highly technical, droplet digital PCR is undergoing a minor revolution as a quality-control tool. A look at new applications. #AdFeature with @BioRadLifeSci

How analyzing billions of novel targets allows 3T Biosciences @3tbio to expand personalized cancer therapy to larger patient populations #AdFeature with @GenScript

Scientists are developing interception methods to stop cells progressing from pre-malignancy to mature cancers #AdFeature with @JanssenGlobal #ASCO20

By providing details about both protein and RNA expression, CITE-seq and REAP-seq allows researchers to fill in the gaps left by flow cytometry or single cell RNA-sequencing #AdFeature with @illumina